Please log in to determine if you are eligible to purchase PT Programs.
ORAL FLUID FOR DRUGS OF ABUSE - OFD
OFD
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
See drug listing 5 Four shipments per year

Program Information

  • Five 2.0‑mL oral fluid specimens
  • For laboratories performing drug screening, confirmation, and quantitation

Shipping Schedule

  • Shipment A: March 4
  • Shipment B: May 28
  • Shipment C: September 3
  • Shipment D: December 2

Challenges will include a mix of drugs from the list below.
Amphetamine Group
Amphetamine
Methamphetamine
Methylenedioxyamphetamine (MDA)
Methylenedioxyethylamphetaine (MDEA)
Methylenedioxymethamphetamine (MDMA)
Benzodiazepine Group
Alprazolam
Diazepam
Nordiazepam
Oxazepam
Temazepam
Buprenorphine
Buprenorphine and norbuprenorphine
Cocaine and/or metabolite
Benzoylecgonine
Cocaine
Cannabinoids
Delta‑9‑THC
Delta-9-THC-COOH
Methadone
Opiate Group
6‑acetylmorphine (6‑AM)
Codeine
Hydrocodone
Hydromorphone
Morphine
Oxycodone
Oxymorphone
Phencyclidine (PCP)